IL#PAZIENTE#VALVOLARE#E#IL#3D - file3D PRINTING OF TRICUSPID VALVE USING 3DTTE Muraru D et al. ESC...
Transcript of IL#PAZIENTE#VALVOLARE#E#IL#3D - file3D PRINTING OF TRICUSPID VALVE USING 3DTTE Muraru D et al. ESC...
Department of Cardiac, Thoracic and Vascular Sciences University of Padua, School of Medicine
Padua, Italy
IL PAZIENTE VALVOLARE E IL 3D
Denisa Muraru, MD, PhD*
*Consultancy and research support – GE Vingmed, TomTec Imaging Systems
• Good image quality
• Anatomic rendering
• Better diagnostic yield
• Unprecedented
quantitation
• Monitoring procedures
3D Echo scanner
3DE IN VALVULAR HEART DISEASE
• 31-year-old woman • MV “incidentaloma” at
transthoracic echo • Sent for TEE
3DE IN VALVULAR HEART DISEASE
Rapid solving of unclear structures
3DE IN VALVULAR HEART DISEASE
Biplane imaging using the matrix probe
Realis>c in vivo anatomy
Atrial perspective (“surgical view”) Ventricular perspective
3DE IN VALVULAR HEART DISEASE
Increased Diagnos>c Yield – “Surgeon’s View”
3DE IN VALVULAR HEART DISEASE
- 73 year-old man - severe organic MR - evaluation for percutaneous Neochord implantation
LAA
Ao
Improved quality of challenging structures
3DE IN VALVULAR HEART DISEASE
Anatomical Details
3DE IN VALVULAR HEART DISEASE
Virtual Anatomy and Quan>ta>on at Pa>ent Bedside
3DE IN VALVULAR HEART DISEASE
New Features during Postprocessing for Enhancing Anatomical Details
3DE IN VALVULAR HEART DISEASE
PiSalls of MV Area Planimetry by 2D Echo
3DE IN VALVULAR HEART DISEASE
3DE IN VALVULAR HEART DISEASE
Assessing Mitral Stenosis Severity
3DE IN VALVULAR HEART DISEASE
Assessing Mitral Stenosis Severity
3DE IN VALVULAR HEART DISEASE
Mitral Stenosis Severity
Rheuma>c MV disease: evalua>on for PMBC indica>on
3DE IN VALVULAR HEART DISEASE
3DE IN VALVULAR HEART DISEASE
3DTEE-Guided PMBC
Ao
LAA
IAS
TV
3DE IN VALVULAR HEART DISEASE
Anatomical details of LAA
3DE IN VALVULAR HEART DISEASE
3DE IN VALVULAR HEART DISEASE
Tricuspid Regurgita>on: Which Mechanism?
TRV max = 2.8 m/s
• 76 year-old lady • Sclerodermia • Pacemaker implantation 10 months before • Known moderate TR • Admitted for decompensated right heart failure
3DE IN VALVULAR HEART DISEASE
Tricuspid Regurgita>on: Which Mechanism?
3DE IN VALVULAR HEART DISEASE
Tricuspid Regurgita>on: No Pacemaker Interference
3DE IN VALVULAR HEART DISEASE
Tricuspid Regurgita>on: a[er 1 week of diure>cs
TRV max = 3.8 m/s
3D PRINTING OF TRICUSPID VALVE USING 3DTTE
Muraru D et al. ESC 2015
Total time for generating the 3D model of TV was 30 min
• The tangible 3D model of TV
enhanced the perception of the complex 3D shape of the TV and of the non-planarity of TV annulus
3D PRINTING OF TRICUSPID VALVE USING 3DTTE
• This technique could be potentially integrated in clinical practice to assist the
surgical planning and education, and the simulation of the outcomes of various percutaneus TV interventions
Muraru D et al. ESC 2015; EuroEcho 2015
Anatomy and Flow
3DE IN VALVULAR HEART DISEASE
When Color Ma]ers
3DE IN VALVULAR HEART DISEASE
Assessing outcome after valve procedures
3DE IN VALVULAR HEART DISEASE
Assessing outcome after valve procedures
• 75 year-old lady • percutaneous closure of periprosthetic leak 6 months before • dyspnea at minimal exertion • haemolysis
3DE IN VALVULAR HEART DISEASE
Perivalvular leak after device closure
3DE IN VALVULAR HEART DISEASE
Perivalvular leak after device closure
3DE IN VALVULAR HEART DISEASE
Other “side-effects” after device closure
3DE IN VALVULAR HEART DISEASE
Other “side-effects” after device closure
3DE IN VALVULAR HEART DISEASE
Other “side-effects” after device closure
Assessing Outcome of Interven>onal Procedures
Clinical case courtesy of Dr. Monica Alcantara
3DE IN VALVULAR HEART DISEASE
Thank you for your attention!